The Neuroscience of Grief and How to Heal Faster According to Brain Science
Huberman explains how the brain remaps lost relationships and which science-backed tools accelerate adaptive grieving.
Cognitive performance, neuroplasticity, dementia prevention, and brain aging research
886 articoli
Huberman explains how the brain remaps lost relationships and which science-backed tools accelerate adaptive grieving.
A chromatin-remodeling gene called SMARCAD1 controls tau levels — and switching it off could be a new therapeutic target for Alzheimer's.
A newly identified proteasome activator, PA200, clears toxic alpha-synuclein aggregates and maintains function even when standard protein-disposal systems fail.
Un'esplorazione meccanicistica approfondita di come la segnalazione ipotalamica IKKβ/NF-κB, la comunicazione esosomiale degli htNSC e la disregolazione ormonale multi-asse guidino l'invecchiamento sistemico — oltre alle strategie terapeutiche all'avanguardia.
New mouse research finds the trendy D+Q senolytic combo severely damages myelin, raising red flags for longevity self-experimenters.
A small trial found tocilizumab, an anti-inflammatory drug, cut depression remission rates better than SSRIs by targeting IL-6, not brain chemistry.
A completed Phase 1/2 pilot trial tested whether the senolytic duo D+Q penetrates the brain in early Alzheimer's disease.
A JAMA Insights review breaks down how hearing aids work, their limits, and whether OTC devices stack up against prescription options.
A landmark review reframes astrocytes as multilayered processing units that regulate synapses, circuits, and brain function at multiple spatial scales.
Vai oltre la superficie per esplorare come la segnalazione di NF-κB, l'attivazione di IKKβ e il declino delle cellule staminali ipotalamiche guidino l'invecchiamento dell'intero organismo — e quali interventi possono rallentare il processo.
A completed RCT tests whether trained non-clinicians can guide self-help CBT for generalized anxiety disorder in seniors.
Researchers respond to critiques of their trial showing positive airway pressure therapy may improve cognitive outcomes in Parkinson's disease.